Regulation of Proinflammatory Signaling Pathways in CFTR
Regulation of Proinflammatory Signaling Pathways in CFTR
批准号:
7275391
负责人:
Harvey Bruce Pollard
金额:
$30.12万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-15 至 2011-08-14
关键词:
AffectAffinityAntibodiesBindingBinding ProteinsBiologyBiopsyCell DeathCell LineCell NucleusCellsChemicalsChemistryChronicComplexCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDNADNA SequenceDataDiseaseDoctor of MedicineDoctor of PhilosophyEpithelial CellsEpitheliumEthanolFormaldehydeFreezingGelshift AnalysisGene TransferGenesGlandGoalsHeatingHeterogeneous-Nuclear RibonucleoproteinsIL8 geneIn VitroIndividualInfectionInflammatoryInformatinInvestigationLaboratoriesLengthLifeLocationLungMapsMass Spectrum AnalysisMethodsMicroarray AnalysisMicrodissectionMolecularMutateMutationNF-kappa BNuclear ExtractNuclear ProteinNuclear ProteinsObstructionPhenotypePropertyProtein BindingProtein MicrochipsProteinsProteomicsRadiolabeledRecoveryRegulationResearch PersonnelRespiratory physiologySamplingSignal PathwaySignal TransductionStructure of parenchyma of lungSurfaceSystemTechnologyTestingTissuesairway inflammationaqueousbasecis acting elementcrosslinkcystic fibrosis patientsdisorder controlexperiencehnRNP A1in vivoinnovationlink proteinmutantprogramspromoterprotein functionradiotracerreconstitutionrepaired
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is the most common fatal autosomal recessive disease in the U.S., and is due to mutations in the CFTR gene. CF is characterized by constitutive hypersecretion of proinflammatory IL-8 from airway epithelial cells, and death usually ensues from chronic airway inflammation and loss of lung function. Our long term goal has therefore been to identify the mechanisms by which CFTR mutations cause constitutive IL-8 secretion from CF lung epithelial cells. Our approach is to identify the proteins which bind to the IL-8 promoter in CF lung epithelial cells, and to determine which one(s) might be responsible for the hyper-productive IL-8 phenotype. Preliminary data show that NFkappaB signaling is critical for IL-8 promoter activity in CF cells. In addition, we find that the protein hnRNP[A2B1] binds to the IL-8 promoter, affects NFkappaB action, and further activates IL-8 expression in CF cells. Based on these and other preliminary data we have hypothesized that hnRNP[A2B1], and possibly other proteins binding to the IL-8 promoter, are responsible for regulating constitutive, NFkappaB-dependent hyperexpression of IL-8 in CF lung epithelial cells. To test this hypothesis in vitro and in vivo, we propose the following specific aims: Specific Aim1: To identify proteins which bind to the IL-8 promoter in CF lung epithelial cells, and to determine their mechanisms of action on IL-8 expression. We will use mass spectrometry and crosslinking studies to identify and chemically validate proteins in nuclear extracts of CF lung epithelial cells which bind to the 167 bp IL-8 promoter DNA. Specific Aim 2: To map the locations and determine the molecular mechanism of interaction for proteins binding to the IL-8 promoter in CF lung epithelial cells. We will test the ability of free wildtype and mutant IL-8 promoter DNA sequences to competitively displace proteins from immobilized IL-8 promoter DNA. Specific Aim 3: To investigate the ensemble of proteins associated with the IL-8 promoter in bronchial lung epithelial cells from CF patients. We will prepare nuclear extracts from expanded cultures of CF and non-CF disease control bronchial brush biopsies of CF patients, and determine the proteins which bind to the IL-8 DNA promoter sequence. Significance, innovation, and uniqueness: This proposal is significant in that successful completion will determine those dysfunctional signaling pathway proteins which are responsible, directly or indirectly, for the proinflammatory lung phenotype of CF. The proposal is both unique and innovative by directing the investigation to the biology and chemistry of the IL-8 promoter in CF lung epithelial cells, both in vitro and in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling
-
批准号:10566710
-
项目类别:
-
资助金额:$66.36万
-
财政年份:2023
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways by CFTR
-
批准号:6433785
-
项目类别:
-
资助金额:$27.34万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways in CFTR
-
批准号:7143989
-
项目类别:
-
资助金额:$31.02万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
PHOSPHOLIPIDS AS CHEMICAL CHAPERONES FOR CFTR
-
批准号:2628917
-
项目类别:
-
资助金额:$21.67万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways by CFTR
-
批准号:6704704
-
项目类别:
-
资助金额:$27.34万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways in CFTR
-
批准号:7477883
-
项目类别:
-
资助金额:$29.52万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
PHOSPHOLIPIDS AS CHEMICAL CHAPERONS FOR CFTR
-
批准号:6448583
-
项目类别:
-
资助金额:$7.41万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways in CFTR
-
批准号:7671433
-
项目类别:
-
资助金额:$29.52万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
PHOSPHOLIPIDS AS CHEMICAL CHAPERONS FOR CFTR
-
批准号:6177917
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
PHOSPHOLIPIDS AS CHEMICAL CHAPERONS FOR CFTR
-
批准号:2906100
-
项目类别:
-
资助金额:$21.2万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways by CFTR
-
批准号:6621298
-
项目类别:
-
资助金额:$27.34万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
Regulation of Proinflammatory Signaling Pathways in CFTR
-
批准号:7907584
-
项目类别:
-
资助金额:$29.22万
-
财政年份:1998
-
负责人:Harvey Bruce Pollard
-
依托单位:
NHLBI PROTEOMICS INITIATIVE-268028187
-
批准号:7191273
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Harvey Bruce Pollard
-
依托单位:
NHLBI PROTEOMICS INITIATIVE-N01HV28187
-
批准号:6994732
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Harvey Bruce Pollard
-
依托单位:
NHLBI PROTEOMICS INITIATIVE-268028187-268028187
-
批准号:7329566
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Harvey Bruce Pollard
-
依托单位:
海外基金